Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH

References

• Caldwell SH, Crespo DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol. 2004;40(4):578–584. doi:10.1016/j.jhep.2004.02.013
   PubMed Web of Science ®Google Scholar
• Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 1997;126(2):137–145. doi:10.7326/0003-4819-126-2-199701150-00008
   PubMedGoogle Scholar
• Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009;51(2):371–379. doi:10.1016/j.jhep.2009.03.019
   PubMed Web of Science ®Google Scholar
• Hossain N, Afendy A, Stepanova M, et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(11):1224–9, 1229.e1-2. doi:10.1016/j.cgh.2009.06.007
   PubMed Web of Science ®Google Scholar
• Francque SMA, Verrijken A, Mertens I, et al. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Clin Gastroenterol Hepatol. 2012;10(10):1162–1168. doi:10.1016/j.cgh.2012.06.019
   PubMed Web of Science ®Google Scholar
• Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413–1419. doi:10.1016/S0016-5085(99)70506-8
   PubMed Web of Science ®Google Scholar
• Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118(6):1117–1123. doi:10.1016/S0016-5085(00)70364-7
   PubMed Web of Science ®Google Scholar
• Petta S, Amato MC, Di Marco V, et al. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012;35(2):238–247. doi:10.1111/apt.2011.35.issue-2
   PubMed Web of Science ®Google Scholar
• Leonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. Dig Liver Dis. 2015;47(3):181–190. doi:10.1016/j.dld.2014.09.020
   PubMedGoogle Scholar
• Pastori D, Baratta F, Novo M, et al. Remnant lipoprotein cholesterol and cardiovascular and cerebrovascular events in patients with non-alcoholic fatty liver disease. J Clin Med. 2018;7(11):378. doi:10.3390/jcm7110378
   PubMedGoogle Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–2023. doi:10.1002/hep.25762
   PubMed Web of Science ®Google Scholar
• Figen CC, Nevil A, Hasan N. Complications and efficiency of liver biopsies using the Tru-Cut biopsy gun. J Infect Dev Ctries. 2010;4:91–95. doi:10.3855/jidc.572
   PubMedGoogle Scholar
• Merat S, Sotoudehmanesh R, Nouraie M, et al. Sampling error in histopathology findings of nonalcoholic fatty liver disease: a post mortem liver histology study. Arch Iran Med. 2012;15:418–421.
   PubMedGoogle Scholar
• Kleiner D, Brunt EM, Natta MV, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321. doi:10.1002/(ISSN)1527-3350
   PubMed Web of Science ®Google Scholar
• Chan YH. Biostatistics102: quantitative data – parametric & non-parametric tests. Singapore Med J. 2003a;44(8):391–396.
   PubMedGoogle Scholar
• Chan YH. Biostatistics 103: qualitative data –tests of independence. Singapore Med J. 2003b;44(10):498–503.
   PubMedGoogle Scholar
• Chan YH. Biostatistics 104: correlational analysis. Singapore Med J. 2003c;44(12):614–619.
   PubMedGoogle Scholar
• Ascaso J, Gonzalez Santos P, Hernandez Mijares A, et al. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum. Am J Cardiovasc Drugs. 2007;7(1):39–58. doi:10.2165/00129784-200707010-00004
   PubMedGoogle Scholar
• Wu KT, Kuo PL, Su SB, et al. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol. J Clin Lipidol. 2016;10(2):420–425. doi:10.1016/j.jacl.2015.12.026
   PubMed Web of Science ®Google Scholar
• Puri P, Wiest MM, Cheung O, et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology. 2009;50(6):1827–1838. doi:10.1002/hep.23229
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterol. 1998;114(4):842–845. doi:10.1016/S0016-5085(98)70599-2
   PubMed Web of Science ®Google Scholar
• Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol. 2013;218(3):R25–36. doi:10.1530/JOE-13-0201
   PubMed Web of Science ®Google Scholar
• Min HK, Kapoor A, Fuchs M, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of the nonalcoholic fatty liver disease. Cell Metab. 2012;15(5):665–674. doi:10.1016/j.cmet.2012.04.004
   PubMed Web of Science ®Google Scholar
• Puri P, Baillie RA, Wiest MM, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46(4):1081–1090. doi:10.1002/(ISSN)1527-3350
   PubMed Web of Science ®Google Scholar
• Ioannou GN, Haigh WG, Thorning D, Savard C. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J Lipid Res. 2013;54(5):1326–1334. doi:10.1194/jlr.M034876
   PubMed Web of Science ®Google Scholar
• Walenbergh MA, Koek GH, Bieghs V, Shiri-Sverdlov R. Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. J Hepatol. 2013;58(4):801–810. doi:10.1016/j.jhep.2012.11.014
   PubMed Web of Science ®Google Scholar
• Hendrikx T, Walenbergh SM, Hofker MH, Shiri-Sverdlov R. Lysosomal cholesterol accumulation: driver on the road to inflammation during atherosclerosis and non-alcoholic steatohepatitis. Obesity Rev. 2014;15(5):424–433. doi:10.1111/obr.12159
   PubMed Web of Science ®Google Scholar
• Tomita K, Teratani T, Suzuki T, et al. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice. Hepatology. 2014;59(1):154–169. doi:10.1002/hep.26604
   PubMed Web of Science ®Google Scholar
• Pacifico L, Bonci E, Andreoli G, et al. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutr Metab Cardiovasc Dis. 2014;24(7):737–743. doi:10.1016/j.numecd.2014.01.010
   PubMed Web of Science ®Google Scholar
• Li XD, Qiu BH, Su FC, Sun SX. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y. Clin Exp Hypertens. 2016;38(7):639–643. doi:10.1080/10641963.2016.1182181
   PubMed Web of Science ®Google Scholar
• Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P. Gender, fatty liver and GGT. Hepatology. 2006;44(1):278–279. doi:10.1002/(ISSN)1527-3350
   PubMedGoogle Scholar
• Pan J, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol. 2014;6(5):274–283. doi:10.4254/wjh.v6.i5.274
   PubMedGoogle Scholar
• Younossi ZM, Stepanova M, Negro F, et al. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine. 2012;91:319–327. doi:10.1097/MD.0b013e3182779d49
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA, Clark JM, Bass NM, et al; NASH Clinical Research Network. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology. 2010;52:913–924. doi:10.1002/hep.23784
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi:10.1002/hep.v64.1
   PubMed Web of Science ®Google Scholar
• Chen Z, Qin H, Qiu S, Chen G, Chen Y. Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research. Lipids Health Dis. 2019;18:162. doi:10.1186/s12944-019-1104-6
   PubMedGoogle Scholar
• Sven MF, Denise VG, Wilhelmus JK. Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol. 2016;65:425–443. doi:10.1016/j.jhep.2016.04.005
   PubMedGoogle Scholar